ICCMNasdaq

IceCure Medical Ltd.

Healthcare·Oncology·Caesarea, Israel
OncologyNephrology

IceCure Medical Ltd. (ICCM): 2 pipeline candidates · ~2 mo cash runway · 3 clinical trials. Updated within the last hour.

5.1/10

BioSniper Score

3-factor signal · derived from public data

Cash Runway0.6

2.1 months

Financial Health10.0

0% dilution

Pipeline MaturityN/A

N/A

Pipeline Breadth4.6

2 candidates

Catalyst MomentumN/A

N/A

Insider SignalN/A

N/A

A transparent, data-derived signal for IceCure Medical Ltd.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.

Key Financials

Market Cap

$18.0M

Cash

$8.9M

Quarterly Burn

$14.6M

Runway

2.1 mo

Revenue

$3.4M

Cash Runway vs Catalysts

Tracked catalysts land within the current projected cash runway.

Cash ends ~Aug 2026
Today~7 mo out
Catalyst within runway

Pipeline (2 candidates)

DrugPhase
prosense™ system
prosense™ system

Institutional Holdings

Source: SEC Form 13F · as of Mar 2026

Institutional holders

13

Total value held

$858K

HolderSharesValue
armistice capital, llc2,712,000$816K
geode capital management, llc40,453$12K
hudson bay capital management lp30,000$9K
morgan stanley17,000$5K
kingdom financial group llc.16,000$5K
foundations investment advisors, llc15,000$5K
wellington shields capital management, llc15,000$5K
jpmorgan chase & co5,950$2K
bartlett & co. wealth management llc250$73
hrt financial lp47,596$14

Showing top 10 of 13 institutional holders of IceCure Medical Ltd.. Sign up for the full 13F holder list and quarter-by-quarter ownership history.

3 clinical trials·CEO: Mr. Eyal Shamir

Frequently asked questions

How many drug candidates are in IceCure Medical Ltd.'s pipeline?

IceCure Medical Ltd. (ICCM) has 2 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.

What is IceCure Medical Ltd.'s cash runway?

Based on its most recent reported cash balance and quarterly burn rate, IceCure Medical Ltd. has approximately 2.1 months of cash runway.

What is IceCure Medical Ltd.'s market capitalization?

IceCure Medical Ltd.'s market capitalization is approximately $18.0M.

Who is the CEO of IceCure Medical Ltd.?

Mr. Eyal Shamir is the chief executive officer of IceCure Medical Ltd. (ICCM).

Get the full picture on IceCure Medical Ltd.

Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.